167 related articles for article (PubMed ID: 9284461)
1. Measurement of serum ionized magnesium in CAPD patients.
Saha HH; Harmoinen AP; Pasternack AI
Perit Dial Int; 1997; 17(4):347-52. PubMed ID: 9284461
[TBL] [Abstract][Full Text] [Related]
2. Calcium and magnesium mass transfer in peritoneal dialysis patients using 1.25 mmol/L calcium, 0.25 mmol/L magnesium dialysis fluid.
Hutchison AJ; Merchant M; Boulton HF; Hinchcliffe R; Gokal R
Perit Dial Int; 1993; 13(3):219-23. PubMed ID: 8369353
[TBL] [Abstract][Full Text] [Related]
3. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
[TBL] [Abstract][Full Text] [Related]
4. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.
Weinreich T; Ritz E; Passlick-Deetjen J
Perit Dial Int; 1996; 16(3):260-8. PubMed ID: 8761540
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of serum ionized magnesium in patients receiving hemodialysis or peritoneal dialysis.
Markell MS; Altura BT; Sarn Y; Delano BG; Ifudu O; Friedman EA; Altura BM
ASAIO J; 1993; 39(3):M801-4. PubMed ID: 8268649
[TBL] [Abstract][Full Text] [Related]
6. Magnesium homeostasis in patients undergoing continuous ambulatory peritoneal dialysis: role of the dialysate magnesium concentration.
Katopodis KP; Koliousi EL; Andrikos EK; Pappas MV; Elisaf MS; Siamopoulos KC
Artif Organs; 2003 Sep; 27(9):853-7. PubMed ID: 12940910
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of intermittent oral alphacalcidol, calcium carbonate and low-calcium dialysis (1.25 mmol L-1) on secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis.
Brandi L; Nielsen PK; Bro S; Daugaard H; Olgaard K
J Intern Med; 1998 Aug; 244(2):121-31. PubMed ID: 10095798
[TBL] [Abstract][Full Text] [Related]
8. Hypomagnesemia in continuous ambulatory peritoneal dialysis patients dialyzed with a low-magnesium peritoneal dialysis solution.
Ejaz AA; McShane AP; Gandhi VC; Leehey DJ; Ing TS
Perit Dial Int; 1995; 15(1):61-4. PubMed ID: 7734563
[TBL] [Abstract][Full Text] [Related]
9. Magnesium and parathyroid hormone changes to magnesium-free dialysate in continuous ambulatory peritoneal dialysis patients.
Takahashi S; Okada K; Yanai M
Perit Dial Int; 1994; 14(1):75-8. PubMed ID: 8312420
[TBL] [Abstract][Full Text] [Related]
10. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
Bro S; Brandi L; Olgaard K
Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
[TBL] [Abstract][Full Text] [Related]
11. Calcium mass transfer and kinetics in CAPD using calcium-free solutions.
Malberti F; Corradi B; Imbasciati E
Adv Perit Dial; 1993; 9():274-9. PubMed ID: 8105942
[TBL] [Abstract][Full Text] [Related]
12. Measurement of serum ionized versus total levels of magnesium and calcium in hemodialysis patients.
Saha H; Harmoinen A; Pietilä K; Mörsky P; Pasternack A
Clin Nephrol; 1996 Nov; 46(5):326-31. PubMed ID: 8953122
[TBL] [Abstract][Full Text] [Related]
13. Hypercalcaemia, hypermagnesaemia, hyperphosphataemia and hyperaluminaemia in CAPD: improvement in serum biochemistry by reduction in dialysate calcium and magnesium concentrations.
Hutchison AJ; Were AJ; Boulton HF; Mawer EB; Laing I; Gokal R
Nephron; 1996; 72(1):52-8. PubMed ID: 8903861
[TBL] [Abstract][Full Text] [Related]
14. Circulating ionized and total magnesium in end-stage kidney disease.
Pedrozzi NE; Truttmann AC; Faraone R; Descoeudres CE; Wermuth B; Lüthy CM; Nuoffer JM; Frey FJ; Bianchetti MG
Nephron; 1998; 79(3):288-92. PubMed ID: 9678428
[TBL] [Abstract][Full Text] [Related]
15. Low calcium dialysate increases cardiac relaxation in CAPD patients.
Tuncer M; Ermiş C; Süleymanlar G; Yakupoglu G; Ersoy FF
Perit Dial Int; 2002; 22(6):714-8. PubMed ID: 12556074
[TBL] [Abstract][Full Text] [Related]
16. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients.
Navarro JF; Mora C; Macia M; Garcia J
Perit Dial Int; 1999; 19(5):455-61. PubMed ID: 11379859
[TBL] [Abstract][Full Text] [Related]
17. Calcium, magnesium mass transfer and lactate balance study in CAPD patients with reduced calcium/magnesium and high lactate dialysis fluid.
Merchant MR; Hutchinson AJ; Butler SJ; Boulton H; Hintchliffe R; Gokal R
Adv Perit Dial; 1992; 8():365-8. PubMed ID: 1361824
[TBL] [Abstract][Full Text] [Related]
18. Calcium mass transfer with 10-hour dwell time using 1.25 versus 1.75 mmol/L calcium dialysate.
Banalagay EE; Bernardini J; Piraino B
Adv Perit Dial; 1993; 9():271-3. PubMed ID: 8105941
[TBL] [Abstract][Full Text] [Related]
19. Clearance of Magnesium in Peritoneal Dialysis Patients: A Single-Center Study.
Li G; Zhang L; Ren H; Huang B; Mao C; Zhou A
Blood Purif; 2019; 47 Suppl 1(Suppl 1):1-7. PubMed ID: 30699418
[TBL] [Abstract][Full Text] [Related]
20. Magnesium fractions in serum of healthy individuals and CAPD patients, measured by an ion-selective electrode and ultrafiltration.
Huijgen HJ; van Ingen HE; Kok WT; Sanders GT
Clin Biochem; 1996 Jun; 29(3):261-6. PubMed ID: 8740513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
